summary
Introduced
03/16/2021
03/16/2021
In Committee
05/18/2021
05/18/2021
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes.
AI Summary
This bill, the "End Taxpayer Funding of Gender Experimentation Act of 2021," prohibits the use of federal funds for gender reassignment medical interventions, such as surgery, puberty-blocking drugs, and hormone therapy. It also prohibits federal health plans, including those under the Affordable Care Act (ACA), from covering these interventions. However, the bill allows individuals to purchase separate coverage for these interventions using non-federal funds. The bill also includes exceptions for individuals born with medically verifiable disorders of sex development. The amendments made by this bill apply to plan years beginning one year after the date of enactment.
Committee Categories
Business and Industry, Health and Social Services, Military Affairs and Security
Sponsors (24)
Doug LaMalfa (R)*,
Robert Aderholt (R),
Rick Allen (R),
Brian Babin (R),
Jim Banks (R),
Lauren Boebert (R),
Ken Buck (R),
Rick Crawford (R),
Jeff Duncan (R),
Bob Good (R),
Paul Gosar (R),
Glenn Grothman (R),
Jody Hice (R),
Jim Jordan (R),
Trent Kelly (R),
Doug Lamborn (R),
Debbie Lesko (R),
Lisa McClain (R),
Mary Miller (R),
Ralph Norman (R),
Matt Rosendale (R),
Chip Roy (R),
Greg Steube (R),
Randy Weber (R),
Last Action
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. (on 05/18/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/house-bill/1927/all-info |
| BillText | https://www.congress.gov/117/bills/hr1927/BILLS-117hr1927ih.pdf |
| Bill | https://www.congress.gov/117/bills/hr1927/BILLS-117hr1927ih.pdf.pdf |
Loading...